
David A. Cooper, MD, DSc, discusses clinical data on the use of integrase inhibitors for the management of treatment-experienced and treatment-naive HIV-infected patients.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recount data from clinical studies of the use of the integrase inhibitors raltegravir and elvitegravir
- Discuss the role of integrase inhibitors in the management of treatment-experienced patients
- Identify management strategies for antiretroviral-experienced patients who experience virologic failure